On Aug 06, 2026, GENI reported earnings of -0.25 USD per share (EPS) for Q2 26, missing the estimate of -0.07 USD, resulting in a -250.14% surprise. Revenue reached 195.50 million, compared to an expected 188.13 million, with a 3.92% difference. The market reacted with a -6.00% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 13 analysts forecast an EPS of 0.01 USD, with revenue projected to reach 266.02 million USD, implying an decrease of -104.00% EPS, and increase of 36.07% in Revenue from the last quarter.